跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23,856 条关于
“Duke Street Bio”
全部
23,856
临床试验
19,547
药物
1,103
机构
328
资讯
2,878
去年
Duke Street Bio Receives EMA Approval for First-in-Human Trial of PARP1 Inhibitor DSB2455
去年
Duke Street Bio Receives FDA Fast Track Designation for Brain-Penetrating PARP1 Inhibitor DSB2455
去年
RedHill Biopharma and Duke University Collaborate to Develop Opaganib for Phosgene Inhalation Injury
去年
Aquestive Therapeutics Advances Anaphylm and Alopecia Treatment, Receives Analyst Boost
2年前
Mirvetuximab Soravtansine Shows Promise in Platinum-Sensitive Ovarian Cancer
7个月前
Merck Forecasts 2026 Revenue Below Wall Street Estimates as Patent Cliff Looms
上个月
Palvella Therapeutics Reports Q2 Loss of $21.9 Million, Missing Wall Street Estimates
2个月前
Federal Grants Expand Street Medicine Training to Bring Care Directly to People Experiencing Homelessness
6个月前
Duke Researchers Develop Nasal Swab Test for Early Alzheimer's Detection
去年
Duke-NUS Receives $1.5M to Advance AI-Powered Antifibrotic Drug Discovery Platform
第 1 页,共 288 页
上一页
下一页